H
Hirohito Tada
Researcher at Chiba University
Publications - 96
Citations - 8968
Hirohito Tada is an academic researcher from Chiba University. The author has contributed to research in topics: Lung cancer & Survival rate. The author has an hindex of 26, co-authored 95 publications receiving 8017 citations. Previous affiliations of Hirohito Tada include Kitasato University & Society of Hospital Medicine.
Papers
More filters
Journal ArticleDOI
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi,Satoshi Morita,Yasushi Yatabe,Shunichi Negoro,Isamu Okamoto,Junji Tsurutani,Takashi Seto,Miyako Satouchi,Hirohito Tada,Tomonori Hirashima,Kazuhiro Asami,Nobuyuki Katakami,Minoru Takada,Hiroshige Yoshioka,Kazuhiko Shibata,Shinzoh Kudoh,Eiji Shimizu,Hiroshi Saito,Shinichi Toyooka,Kazuhiko Nakagawa,Masahiro Fukuoka +20 more
TL;DR: In this article, an open label, phase 3 study (WJTOG3405) with recruitment between March 31, 2006, and June 22, 2009, at 36 centers in Japan was conducted.
Journal ArticleDOI
A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung
Harubumi Kato,Yukito Ichinose,Morio Ohta,Enjo Hata,Noriaki Tsubota,Hirohito Tada,Yoh Watanabe,Hiromi Wada,Masahiro Tsuboi,Nobuyuki Hamajima,Mitsuo Ohta +10 more
TL;DR: In this article, a combination of uracil and tegafur (often referred to as UFT) taken orally was shown to prolong survival in non-small-cell lung cancer.
Journal ArticleDOI
Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib
Takayuki Kosaka,Yasushi Yatabe,Hideki Endoh,Kimihide Yoshida,Toyoaki Hida,Masahiro Tsuboi,Hirohito Tada,Hiroyuki Kuwano,Tetsuya Mitsudomi +8 more
TL;DR: A secondary T790M mutation of EGFR accounted for half the tumors with acquired resistance to gefitinib in Japanese patients, and other drug-resistant secondary mutations are uncommon in the EGFR gene.
Journal ArticleDOI
A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L)
Kenichi Nakamura,Hisashi Saji,Ryu Nakajima,Morihito Okada,Hisao Asamura,Taro Shibata,Shinichiro Nakamura,Hirohito Tada,Masahiro Tsuboi +8 more
TL;DR: A Phase III study was started in Japan to evaluate the non-inferiority in overall survival of segmentectomy compared with lobectomy in patients with small-sized peripheral non-small cell lung cancer, excluding radiologically determinednon-invasive cancer.
Journal ArticleDOI
A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201).
Kenji Suzuki,Teruaki Koike,Takashi Asakawa,Masahiko Kusumoto,Hisao Asamura,Kanji Nagai,Hirohito Tada,Tetsuya Mitsudomi,Masahiro Tsuboi,Taro Shibata,Haruhiko Fukuda,Harubumi Kato +11 more
TL;DR: Although the predetermined criterion for specificity was not statistically confirmed, radiological diagnosis of noninvasive lung cancer with a thin-section computed tomography scan corresponded well with pathological invasiveness.